Risk and incidence of breast cancer in transgender individuals: a systematic review and meta-analysis

Author:

Corso Giovanni123,Gandini Sara4,D’Ecclesiis Oriana4,Mazza Manuelita5,Magnoni Francesca1,Veronesi Paolo12,Galimberti Viviana1,La Vecchia Carlo6

Affiliation:

1. Division of Breast Surgery, European Institute of Oncology (IEO), IRCCS

2. Department of Oncology and Hemato-Oncology, University of Milan

3. European Cancer Prevention Organization (ECP)

4. Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS

5. Division of Medical Senology, European Institute of Oncology (IEO), IRCCS

6. Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

Abstract

Background and aims The risk of developing breast cancer in transgender individuals [male-to-female (MtF) or female-to-male (FtM)] is still inadequately quantified. We aimed to evaluate the impact of breast cancer in this population. Methods We conducted a systematic literature search and review using the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines through the PUBMED and SCOPUS databases. We identified six cohort studies (for both populations) plus 35 case reports. Incidence and breast cancer risk quantification were the main outcomes considered. Results FtM individuals had a higher risk of developing breast cancer in comparison to cisgender men [standardized incidence ratio (SIR) = 63.4; 95% confidence interval (CI), 32.2–124.9] but a lower risk than cisgender women (SIR = 0.42; 95% CI, 0.07–2.41). Similarly, MtF individuals were at higher risk of developing breast cancer in comparison to cisgender men (SIR = 22.5; 95% CI, 5.54–91.8) and at lower risk than cisgender women (SIR = 0.30; 95% CI, 0.22–0.42). Conclusion In this systematic study and meta-analysis, we identified that FtM and MtF individuals are at substantially higher risk of developing breast cancer in comparison to cisgender men, though at lower risk than cisgender women. These individuals, in the absence of defined guidelines for breast cancer prevention, should periodically undergo breast or chest examinations.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Public Health, Environmental and Occupational Health,Oncology,Epidemiology

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Disparities in Breast Cancer Diagnostics: How Radiologists Can Level the Inequalities;Cancers;2023-12-27

2. Câncer de Mama na População LGBTQIA+;Revista Brasileira de Cancerologia;2023-12-22

3. Breast Cancer in Transgender Individuals: Challenges and Perspectives;Modern Care Journal;2023-11-07

4. High-risk Behaviors in Sex-Reassigned Trans-sexual People in Tehran, Iran;International Journal of High Risk Behaviors and Addiction;2023-06-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3